From theheart.org on Medscape

News from the

European Society of Cardiology (ESC) Congress 2015

August 29 - September 02, 2015; London, United Kingdom

The Cardiology Show

The Cardiology Show From ESC 2015 with Dr Valentin Fuster UPDATED with Transcript // The panel discuss a leadless pacemaker, cyclosporine and reperfusion injury, hypertension treatments, high-sensitivity troponin for early MI diagnosis, and yet more data on antithrombins for PCI.

Meeting Highlights at a Glance

Top News From ESC 2015: Slideshow Headlines from the world's largest cardiology meeting include new data on heart failure, CAD and antiplatelet therapy after PCI, plus the promise of a leadless pacemaker.

Conference News

ESC New Directions for Treating NSTE-ACS Patients: ESC
Heartwire from Medscape, September 15, 2015
ESC LCZ696 Doesn't Hurt, May Help Renal Function in HF: Analyses
Heartwire from Medscape, September 11, 2015
ESC Pericardial Fat, Calcium Score Elevated in Patients with HTN
Heartwire from Medscape, September 11, 2015
ESC Idarucizumab May Reverse Anticoagulation Before Emergency Surgery
Heartwire from Medscape, September 10, 2015
ESC Digoxin Safe in Heart-Failure Patients With AF in Danish Cohort
Heartwire from Medscape, September 10, 2015
ESC Telmisartan for HTN Bests Non-ARBs in Biomarker Impact in Study
Heartwire from Medscape, September 9, 2015
ESC Quality of Cardiac Drugs in Sub-Saharan Africa: 'A Disaster'
Heartwire from Medscape, September 9, 2015
ESC Endurance Sports May Affect Female, Male Hearts Differently
Heartwire from Medscape, September 9, 2015
ESC Absorb Stent Comparable to Xience in Two Trials
Heartwire from Medscape, September 8, 2015
ESC PRESERVATION 1: Gel Does Not Help Heart Heal After Large MI
Heartwire from Medscape, September 8, 2015
ESC Coffee Tied to MI Risk in Younger Adults With Mild Hypertension
Heartwire from Medscape, September 8, 2015
ESC Quashing Parasite Doesn't BENEFIT in Chagasic Heart Disease
Heartwire from Medscape, September 4, 2015
ESC CV-Outcomes Trials With Diabetes Drugs: 'A Waste of Resources'
Medscape Medical News, September 3, 2015
ESC OptiLink HF: Impedance Telemonitoring Doesn't Improve Survival
Heartwire from Medscape, September 3, 2015
ESC SCOT: Good Risk/Benefit Trade-Off With Celecoxib, Other NSAIDs
Heartwire from Medscape, September 2, 2015
ESC PROMPT: LV Pacing Doesn't Prevent Remodeling After Large MI
Heartwire from Medscape, September 2, 2015
ESC Diuretic Combo Lowers BP, No Effect on Glucose Metabolism
Heartwire from Medscape, September 2, 2015
ESC PLATFORM: FFRCT Reduces Unnecessary Caths in Stable CAD
Heartwire from Medscape, September 2, 2015
ESC MATRIX: Is There A Benefit From Longer Bivalirudin Infusion?
Heartwire from Medscape, September 1, 2015

ESC CSA Therapy Neutral on Outcomes, Hints at Raised Mortality
Heartwire from Medscape, September 1, 2015
ESC Small Hearts, Thick Walls in Stable CAD Predict Remodeling
Heartwire from Medscape, September 1, 2015
ESC TECOS Subanalysis: No Heart-Failure Risk With Sitagliptin (Januvia)
Heartwire from Medscape, September 1, 2015
ESC PARAMETER: LCZ696 Bests Olmesartan in Decreasing Arterial Stiffness
Heartwire from Medscape, September 1, 2015
ESC St Jude Leadless Pacemaker Shows Potential in US Premarket Study
Heartwire from Medscape, August 31, 2015
ESC ARTS-HF: Finerenone a Promise for Worsening HF in Diabetes/CKD
Medscape Medical News, August 31, 2015
ESC OPTIDUAL: More Debate on Length of Dual Antiplatelet Therapy Post-DES
Heartwire from Medscape, August 31, 2015
ESC Spironolactone Effectively Lowers BP in Resistant Hypertension
Heartwire from Medscape, August 31, 2015
ESC BELIEF: Isolating Left Atrial Appendage May Halt Persistent AF
Heartwire from Medscape, August 31, 2015
ESC IMPROVE-IT: Diabetics Benefit With Ezetimibe, but Is It Enough?
Medscape Medical News, August 31, 2015
ESC No Effect of Educational Program on Apixaban Adherence
Heartwire from Medscape, August 30, 2015
ESC AF Recurs Despite Strategies Added to AF Ablation in Trials
Heartwire from Medscape, August 30, 2015
ESC ALBATROSS: Aldosterone Antagonists 'Not Warranted' in MI Patients
Heartwire from Medscape, August 30, 2015
ESC BACC: High-Sensitivity Troponin I Test Accelerates MI Triage
Heartwire from Medscape, August 30, 2015
ESC CHA2DS2-Vasc Score Predicts Stroke/Embolic Risk in HF
Heartwire from Medscape, August 30, 2015
ESC CIRCUS: No Cyclosporine Benefit in STEMI PCI Setting
Heartwire from Medscape, August 30, 2015
ESC Siesta Therapy: Midday Naps Extend BP Lowering in Treated HTN
Heartwire from Medscape, August 29, 2015
ESC Depression Plus BP Extremes May Increase CV Event Risks
Heartwire from Medscape, August 29, 2015
ESC London Calling: Clinical Clues to Heart Disease Await at ESC 2015
Heartwire from Medscape, August 24, 2015

Perspectives from ESC

European Consensus Statement on Acute HF Management
Alexandre Mebazaa, MD, PhD
Biomarkers Update: High-Sensitivity Troponin and BNP
Ileana L. Piña, MD, MPH; James L. Januzzi
ESC 2015: Positive-in-the-Wrong-Direction Trials, and Others
Michael J. Mack, MD; Carina Blomström-Lundqvist, MD, PhD; John G.F. Cleland, MD
Clinical Implications of Visceral Obesity
Jean-Pierre Després, PhD
Lessons From London: A Quick Cardiology Update for Primary Care Providers
John Mandrola, MD; Laurie Scudder, DNP, NP
High-Sensitivity Troponin for Rapid MI Rule-In/Rule-Out
Dirk Westermann, MD, PhD
CUPID 2: No Love for Gene Therapy in HF
Ileana L. Piña, MD, MPH;
Barry H. Greenberg, MD
ESC Interventional Cardiology Highlights
Keith A.A. Fox, MBChB, FRCP, FMedSci; Gregg W. Stone, MD
Reversing New Oral Anticoagulants: New Agents on the Horizon
Samuel Z. Goldhaber, MD; Charles V. Pollack, Jr, MD
LEADLESS II: Dr Vivek Reddy Interviewed
John M. Mandrola, MD; Vivek Y. Reddy, MD

Bloggers from the Floor

Doubting the BELIEF Trial on LAA Isolation This trial of extensive ablation and left atrial appendage isolation in patients with persistent AF leaves Dr Mandrola concerned that the benefits of a less-is-more approach may be forgotten.
Gender Bias Okay When Evaluating the Heart's Response to Exercise Dr John Mandrola discusses a presentation on the physical changes in the hearts of male and female athletes.
Cutting the Cord in Cardiac Pacing—Finally! Dr John Mandrola reports on LEADLESS II and the future of leadless pacing.
Is the CHA2DS2-Vasc Useful Beyond Atrial Fibrillation? Dr John Mandrola looks into the science of why anticoagulant drugs in some patients with heart failure might be successful at reducing the risk of stroke.
TAVI: A Solution for All Patients: A Pro-Con Debate at ESC 2015 Dr John Mandrola reports on a debate centered on who should undergo TAVI vs surgical aortic-valve replacement as well as one on whether very high-risk patients should receive the procedure.
Debating NOACs vs Warfarin for PE: A Boxing Match Dr Walton-Shirley takes on the role of sports reporter as she gives a blow-by-blow account of a debate on treating pulmonary embolism.
Imagine Our World if We Taught It How to Eat Dr Walton-Shirley recounts a session on healthy eating, a fight against trans fats, the poor record of supplements in clinical trials and urges her fellow physicians to join her in the battle to get people to eat what's good for them.
One-Liners From ESC 2015 Day 1 Dr Melissa Walton-Shirley zips through the take-home messages of 23 presentations.

Live Blog

News and Views from ESC 2015 Coverage of key advances and expert reactions as they happened at the meeting.

Previous Coverage